A drug used by millions of people for decades is attracting the attention of researchers for a benefit that may go far beyond glucose management. New scientific investigations have pointed to a surprising effect that, if confirmed by future analyses, could mean a significant advance for eye health.
This finding is of great interest as it addresses one of the main causes of visual deterioration in older individuals. Although it does not change current therapeutic approaches, the finding opens doors for further studies and highlights the potential of a medicine that is already widely known and accessible.
Breakthrough Research on Metformin and Macular Degeneration
The medication in question is metformin, widely used to control type 2 diabetes. According to a study published in the scientific journal BMJ Open Ophthalmology, continuous administration of this substance was associated with a 37% decrease in the progression of Age-Related Macular Degeneration (AMD) in its intermediate phase. This reduction is notable, especially as it involves metformin, a low-cost drug with wide global availability, which could democratize access to a potential preventive treatment if the results are validated.
Details of the scientific investigation into the use of the medicine
The research followed approximately 2,000 individuals diagnosed with type 2 diabetes over five years. Even after the scientists adjusted the data for variables such as age, gender, duration of diabetes, blood glucose control and the presence of diabetic retinopathy, the link between the use of metformin and a shorter progression of the disease remained statistically relevant.
AMD directly impacts the macula, an area of the retina crucial for central vision and perception of details. As this condition progresses, simple daily tasks, such as reading, recognizing faces or distinguishing colors, can become progressively more difficult.
Proposed mechanisms for the protective action of metformin on vision
Experts explain that metformin has beneficial effects that go beyond controlling blood sugar levels. The medication also interferes with cellular processes linked to aging, helping to reduce oxidative stress and inflammation, both factors often associated with worsening macular degeneration.
Additionally, experimental research suggests that the substance activates a cellular pathway called AMPK, which plays a role in energy production and protection of retinal cells. This mechanism can favor the survival of photoreceptors and improve cellular functionality, explaining the great interest of the scientific community.
Important limitations of the current study methodology
Despite the promising results, the researchers themselves issued a relevant warning. The study in question is observational in nature, which means that it only established a correlation between the use of metformin and a slower progression of the disease, without, however, proving that the medication is the direct cause of this benefit.
Another crucial aspect is that all research participants had type 2 diabetes. Therefore, there is still no evidence to conclude that the same protective effect would occur in individuals who do not have the disease.
Future perspectives for the ocular application of metformin
While new studies are planned and initiated, some biotechnology companies are already exploring methods to administer metformin directly into the eyes, through eye drops or intraocular injections. The objective is to deliver the medication in a more concentrated form to the retina to optimize its possible protective effect.
These investigations are currently in the early stages and will require a series of rigorous clinical trials before any new therapeutic options can be made available to patients.
Current recommendations for prevention and treatment of the disease
At the moment, there is no medical recommendation for the use of metformin to prevent or treat age-related macular degeneration without appropriate professional guidance. Treatment for AMD follows current guidelines, which include regular follow-up with an ophthalmologist, control of risk factors, a balanced diet, management of blood pressure, cholesterol levels, body weight and stopping smoking.
Although the discovery is seen with optimism, experts emphasize the need for additional clinical studies to confirm whether the drug can, in fact, become an effective resource in protecting vision in the future.
